JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM) (JSPRW) Income Statement

US Stock MarketDetailed Quotes

JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM) Watchlist

0.1200 0.00000.00% Close 06/08 16:00 ET

0.1587High0.1110Low1.26KVolume

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)2023/03/31
(FY)2022/12/31
(Q4)2022/12/31
(Q3)2022/09/30
(Q2)2022/06/30
(Q1)2022/03/31
(FY)2021/12/31
(Q4)2021/12/31
(Q3)2021/09/30
(Q2)2021/06/30

(Q1)2023/03/31
(FY)2022/12/31
(Q4)2022/12/31
(Q3)2022/09/30
(Q2)2022/06/30
(Q1)2022/03/31
(FY)2021/12/31
(Q4)2021/12/31
(Q3)2021/09/30
(Q2)2021/06/30

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

9.15%13.95M

38.99%51.2M

13.78%13.75M

26.08%12.71M

42.11%11.96M

104.32%12.78M

78.08%36.83M

102.79%12.08M

67.76%10.08M

8.42M

Selling and administrative expenses

-9.76%4.14M

45.19%16.57M

30.36%4.47M

27.50%3.69M

17.35%3.83M

150.27%4.59M

137.75%11.41M

161.25%3.43M

94.29%2.89M

--3.26M

-General and administrative expense

-9.76%4.14M

45.19%16.57M

30.36%4.47M

27.50%3.69M

17.35%3.83M

150.27%4.59M

137.75%11.41M

161.25%3.43M

94.29%2.89M

--3.26M

Research and development costs

19.75%9.81M

36.21%34.63M

7.22%9.28M

25.51%9.02M

57.78%8.14M

85.25%8.19M

60.05%25.42M

86.29%8.66M

59.03%7.19M

--5.16M

Operating profit

-9.15%-13.95M

-38.99%-51.2M

-13.78%-13.75M

-26.08%-12.71M

-42.11%-11.96M

-104.32%-12.78M

-78.08%-36.83M

-102.79%-12.08M

-67.76%-10.08M

-8.42M

Net non-operating interest income expense

54,700.00%1.1M

3,077.78%268K

91.89%-9K

Non-operating interest income

54,700.00%1.1M

----

--268K

----

--2K

----

Non-operating interest expense

----

-91.89%9K

----

Other net income (expense)

-113.33%-1.41M

118.06%13.51M

-72.82%821K

-91.36%577K

38,875.00%1.56M

401.97%10.57M

156.40%6.2M

173.29%3.02M

241.86%6.68M

Gain on sale of security

-109.50%-575K

339.92%7.2M

200.00%150K

-65.56%155K

--845K

272.81%6.05M

72.40%-3M

101.25%50K

109.56%450K

----

Special income (charges)

-116.63%-764K

-38.29%5.73M

-97.21%85K

-93.22%422K

--625K

--4.59M

--9.28M

--3.05M

--6.23M

--0

-Less：Restructuring and merger&acquisition

116.63%764K

38.29%-5.73M

97.21%-85K

93.22%-422K

---625K

---4.59M

---9.28M

---3.05M

---6.23M

--0

Other non- operating income (expenses)

5.41%-70K

832.50%586K

----

2,125.00%89K

-7,500.00%-74K

27.93%-80K

----

--4K

Income before tax

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.4M

77.37%-2.21M

3.26%-30.64M

9.31%-9.06M

68.48%-3.41M

-8.41M

Income tax

Net income

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.4M

77.37%-2.21M

3.26%-30.64M

9.31%-9.06M

68.48%-3.41M

-8.41M

Net income continuous Operations

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.4M

77.37%-2.21M

3.26%-30.64M

9.31%-9.06M

68.48%-3.41M

---8.41M

Minority interest income

Net income attributable to the parent company

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.4M

77.37%-2.21M

3.26%-30.64M

9.31%-9.06M

68.48%-3.41M

-8.41M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-546.13%-14.26M

-23.00%-37.69M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.4M

77.37%-2.21M

3.26%-30.64M

9.31%-9.06M

68.48%-3.41M

-8.41M

Basic earnings per share

Diluted earnings per share

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)2023/03/31	(FY)2022/12/31	(Q4)2022/12/31	(Q3)2022/09/30	(Q2)2022/06/30	(Q1)2022/03/31	(FY)2021/12/31	(Q4)2021/12/31	(Q3)2021/09/30	(Q2)2021/06/30
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	9.15%13.95M	38.99%51.2M	13.78%13.75M	26.08%12.71M	42.11%11.96M	104.32%12.78M	78.08%36.83M	102.79%12.08M	67.76%10.08M	8.42M
Selling and administrative expenses	-9.76%4.14M	45.19%16.57M	30.36%4.47M	27.50%3.69M	17.35%3.83M	150.27%4.59M	137.75%11.41M	161.25%3.43M	94.29%2.89M	--3.26M
-General and administrative expense	-9.76%4.14M	45.19%16.57M	30.36%4.47M	27.50%3.69M	17.35%3.83M	150.27%4.59M	137.75%11.41M	161.25%3.43M	94.29%2.89M	--3.26M
Research and development costs	19.75%9.81M	36.21%34.63M	7.22%9.28M	25.51%9.02M	57.78%8.14M	85.25%8.19M	60.05%25.42M	86.29%8.66M	59.03%7.19M	--5.16M
Operating profit	-9.15%-13.95M	-38.99%-51.2M	-13.78%-13.75M	-26.08%-12.71M	-42.11%-11.96M	-104.32%-12.78M	-78.08%-36.83M	-102.79%-12.08M	-67.76%-10.08M	-8.42M
Net non-operating interest income expense	54,700.00%1.1M			3,077.78%268K		2K			91.89%-9K
Non-operating interest income	54,700.00%1.1M	----	----	--268K	----	--2K	----	----	----	----
Non-operating interest expense	----	----	----	----	----	----	----	----	-91.89%9K	----
Other net income (expense)	-113.33%-1.41M	118.06%13.51M	-72.82%821K	-91.36%577K	38,875.00%1.56M	401.97%10.57M	156.40%6.2M	173.29%3.02M	241.86%6.68M	4K
Gain on sale of security	-109.50%-575K	339.92%7.2M	200.00%150K	-65.56%155K	--845K	272.81%6.05M	72.40%-3M	101.25%50K	109.56%450K	----
Special income (charges)	-116.63%-764K	-38.29%5.73M	-97.21%85K	-93.22%422K	--625K	--4.59M	--9.28M	--3.05M	--6.23M	--0
-Less：Restructuring and merger&acquisition	116.63%764K	38.29%-5.73M	97.21%-85K	93.22%-422K	---625K	---4.59M	---9.28M	---3.05M	---6.23M	--0
Other non- operating income (expenses)	5.41%-70K	832.50%586K	----	----	2,125.00%89K	-7,500.00%-74K	27.93%-80K	----	----	--4K
Income before tax	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M	-23.65%-10.4M	77.37%-2.21M	3.26%-30.64M	9.31%-9.06M	68.48%-3.41M	-8.41M
Income tax
Net income	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M	-23.65%-10.4M	77.37%-2.21M	3.26%-30.64M	9.31%-9.06M	68.48%-3.41M	-8.41M
Net income continuous Operations	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M	-23.65%-10.4M	77.37%-2.21M	3.26%-30.64M	9.31%-9.06M	68.48%-3.41M	---8.41M
Minority interest income
Net income attributable to the parent company	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M	-23.65%-10.4M	77.37%-2.21M	3.26%-30.64M	9.31%-9.06M	68.48%-3.41M	-8.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-546.13%-14.26M	-23.00%-37.69M	-45.87%-13.21M	-247.68%-11.86M	-23.65%-10.4M	77.37%-2.21M	3.26%-30.64M	9.31%-9.06M	68.48%-3.41M	-8.41M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Paper Trade Start

Symbol

Direction

Buy

Sell

Types

LMT Order

Price

QTY

Amount

Buy